F Smeets1, T Lataster, R van Winkel, R de Graaf, M Ten Have, J van Os. 1. Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, the Netherlands. f.smeets@maastrichtuniversity.nl
Abstract
OBJECTIVE: While hallucinations and delusions are often considered as a single class of 'positive symptoms', little is known about their dynamic cooccurrence in relation to clinical outcome in non-help-seeking people. METHOD: The Netherlands Mental Health and Incidence Study (NEMESIS-1) is a longitudinal study of mental disorders (n = 7075) with three measurements over a 3-year period. Risk factors, persistence of psychotic experiences, and clinical outcome were analyzed for groups with: i) no psychotic experiences, ii) only delusions, iii) only hallucinations, and iv) both delusions and hallucinations. RESULTS: Hallucinations and delusions occurred together more often (T0, 3.5%; T1, 1.0%; T2, 0.9%) than that predicted by chance (T0, 1.0%; T1, 0.1%; T2, 0.04%). The group with both symptoms showed more 'first-rank'-like delusions compared with the group with only delusions. Having both hallucinations and delusions, compared to isolated symptoms, was associated more strongly with risk factors, comorbid affective symptoms, negative symptoms, and persistence of psychotic experiences. This was not an artifact of having more symptoms in general. CONCLUSION: Experiencing both delusions and hallucinations is an indicator of greater etiological load resulting in more clinical outcome. A specific 'hallucinatory-delusional state' may represent an early phase of exacerbation of aberrant attribution of salience, increasing risk for clinical outcome.
OBJECTIVE: While hallucinations and delusions are often considered as a single class of 'positive symptoms', little is known about their dynamic cooccurrence in relation to clinical outcome in non-help-seeking people. METHOD: The Netherlands Mental Health and Incidence Study (NEMESIS-1) is a longitudinal study of mental disorders (n = 7075) with three measurements over a 3-year period. Risk factors, persistence of psychotic experiences, and clinical outcome were analyzed for groups with: i) no psychotic experiences, ii) only delusions, iii) only hallucinations, and iv) both delusions and hallucinations. RESULTS:Hallucinations and delusions occurred together more often (T0, 3.5%; T1, 1.0%; T2, 0.9%) than that predicted by chance (T0, 1.0%; T1, 0.1%; T2, 0.04%). The group with both symptoms showed more 'first-rank'-like delusions compared with the group with only delusions. Having both hallucinations and delusions, compared to isolated symptoms, was associated more strongly with risk factors, comorbid affective symptoms, negative symptoms, and persistence of psychotic experiences. This was not an artifact of having more symptoms in general. CONCLUSION: Experiencing both delusions and hallucinations is an indicator of greater etiological load resulting in more clinical outcome. A specific 'hallucinatory-delusional state' may represent an early phase of exacerbation of aberrant attribution of salience, increasing risk for clinical outcome.
Authors: Lotta-Katrin Pries; Sinan Guloksuz; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Nicole Gunther; Christian Rauschenberg; Ulrich Reininghaus; Rajiv Radhakrishnan; Maarten Bak; Bart P F Rutten; Jim van Os Journal: Schizophr Bull Date: 2018-06-06 Impact factor: 9.306
Authors: Martine van Nierop; Tineke Lataster; Feikje Smeets; Nicole Gunther; Catherine van Zelst; Ron de Graaf; Margreet ten Have; Saskia van Dorsselaer; Maarten Bak; Inez Myin-Germeys; Wolfgang Viechtbauer; Jim van Os; Ruud van Winkel Journal: Schizophr Bull Date: 2014-03 Impact factor: 9.306
Authors: Sara Siddi; Susana Ochoa; Aida Farreny; Gildas Brébion; Frank Larøi; Jorge Cuevas-Esteban; Josep Maria Haro; Christian Stephan-Otto; Antonio Preti Journal: Int J Methods Psychiatr Res Date: 2018-09-20 Impact factor: 4.035
Authors: S C Jacobson McEwen; C G Connolly; A M C Kelly; I Kelleher; E O'Hanlon; M Clarke; M Blanchard; S McNamara; D Connor; E Sheehan; G Donohoe; M Cannon; H Garavan Journal: Acta Psychiatr Scand Date: 2013-04-26 Impact factor: 6.392
Authors: Pia Jeppesen; Janne Tidselbak Larsen; Lars Clemmensen; Anja Munkholm; Martin Kristian Rimvall; Charlotte Ulrikka Rask; Jim van Os; Liselotte Petersen; Anne Mette Skovgaard Journal: Schizophr Bull Date: 2014-12-01 Impact factor: 9.306
Authors: John J McGrath; Sukanta Saha; Ali O Al-Hamzawi; Jordi Alonso; Laura Andrade; Guilherme Borges; Evelyn J Bromet; Mark Oakley Browne; Ronny Bruffaerts; Jose M Caldas de Almeida; John Fayyad; Silvia Florescu; Giovanni de Girolamo; Oye Gureje; Chiyi Hu; Peter de Jonge; Viviane Kovess-Masfety; Jean Pierre Lepine; Carmen C W Lim; Fernando Navarro-Mateu; Maria Piazza; Nancy Sampson; José Posada-Villa; Kenneth S Kendler; Ronald C Kessler Journal: Schizophr Bull Date: 2016-04-02 Impact factor: 9.306
Authors: Laila Hasmi; Lotta-Katrin Pries; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Maarten Bak; Gunter Kenis; Alexander Richards; Bochao D Lin; Michael C O'Donovan; Jurjen J Luykx; Bart P F Rutten; Sinan Guloksuz; Jim van Os Journal: Epidemiol Psychiatr Sci Date: 2021-07-06 Impact factor: 6.892